Halma plc (HLMA) is a leading conglomerates business based in the UK. Halma is listed on the London Stock Exchange (LSE) and employs 6,992 staff. All prices are listed in pence sterling.
|52-week range||1648.0061p - 2637p|
|50-day moving average||2464.3823p|
|200-day moving average||2348.1267p|
|Wall St. target price||1370.42p|
|Dividend yield||0.14p (0.53%)|
|Earnings per share (TTM)||46.6p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Halma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Halma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Halma's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 55x. In other words, Halma shares trade at around 55x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Halma's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Halma's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Halma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £296.6 million.
The EBITDA is a measure of a Halma's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£1.3 billion|
|Operating margin TTM||17.68%|
|Gross profit TTM||£669.6 million|
|Return on assets TTM||7.94%|
|Return on equity TTM||16.13%|
|Market capitalisation||£9.8 billion|
TTM: trailing 12 months
Dividend payout ratio: 3658.7% of net profits
Recently Halma has paid out, on average, around 3658.7% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.53% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Halma shareholders could enjoy a 0.53% return on their shares, in the form of dividend payments. In Halma's case, that would currently equate to about 0.14p per share.
Halma's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 24 December 2020 (the "ex-dividend date").
Halma's shares were split on a 4:3 basis on 11 August 1997. So if you had owned 3 shares the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Halma shares – just the quantity. However, indirectly, the new 25% lower share price could have impacted the market appetite for Halma shares which in turn could have impacted Halma's share price.
Over the last 12 months, Halma's shares have ranged in value from as little as 1648.0061p up to 2637p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Halma's is 0.2993. This would suggest that Halma's shares are less volatile than average (for this exchange).
Halma plc provides technology solutions in the safety, health, and environmental markets. It operates through four segments: Process Safety, Infrastructure Safety, Environmental & Analysis, and Medical. The Process Safety segment offers specialized interlocks that control critical processes safely; instruments that detect flammable and hazardous gases; and explosion protection and corrosion monitoring systems. This segment serves the gas detection, industrial access control, pressure management, and safe storage and transfer markets. The Infrastructure Safety segment provides fire detection systems, specialist fire suppression systems, elevator safety systems, people and vehicle flow technologies, and security sensors. It serves the fire detection and suppression, and elevator markets. The Environmental & Analysis segment offers opto-electronic technology and sensors, flow gap measurement instruments, and gas conditioning products, as well as solutions for environmental data recording, water quality testing, water distribution network monitoring, and UV water treatment. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Medical segment provides devices that assess eye health; assist with eye surgery and primary care applications; critical fluidic components used by medical diagnostics and original equipment manufacturers; and laboratory devices and sensor technologies used in hospitals to understand patient health. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.